Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 12104159 PIKFYVE antisense oligonucleotides

Patent 12104159 was granted and assigned to AcuraStem on October, 2024 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

0

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Wen-Hsuan Chang0

Emily Elizabeth Lee0

Date of Patent

October 1, 2024

0

Patent Application Number

178082470

Date Filed

June 22, 2022

0

Patent Citations

US Patent 7750131 5′-modified bicyclic nucleic acid analogs

0

US Patent 8030467 5′-modified bicyclic nucleic acid analogs

0

US Patent 8034909 Oligonucleotide analogues

0

US Patent 8080644 Oligonucleotide analogues

0

US Patent 8088746 Bis-modified bicyclic nucleic acid analogs

0

US Patent 8153365 Oligonucleotide analogues

0

US Patent 8268980 5′-modified bicyclic nucleic acid analogs

0

US Patent 8501805 Substituted alpha-L-bicyclic nucleosides

0

...

Patent Primary Examiner

Amy Rose Hudson

0

CPC Code

0

0

Patent abstract

The present invention relates to PIKFYVE antisense oligonucleotides (ASOs), pharmaceutical compositions containing them, and methods for treating, inhibiting, suppressing, and preventing neurological diseases with them.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 12104159 PIKFYVE antisense oligonucleotides

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool